Arrowhead Pharmaceuticals

ISIN US04280A1007

 | 

WKN A2AGYB

Market cap (in EUR)
6.736 m
Country
Verenigde Staten
Sector
Gezondheidszorg
Dividend yield
0,00%
 

Overview

Description

Arrowhead Pharmaceuticals, Inc. is een biofarmaceutisch bedrijf dat zich bezighoudt met de ontwikkeling van geneesmiddelen voor de behandeling van hardnekkige ziekten door het uitschakelen van de genen die deze ziekten veroorzaken. Tot de preklinische kandidaat-geneesmiddelen van het bedrijf behoren ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV en ARO-ENaC. Het bedrijf werd in 1989 opgericht door Robert Bruce Stewart en het hoofdkantoor is gevestigd in Pasadena, CA.
Show more Show less
Gezondheidszorg Biofarmaceutica Systeemspecifieke Biofarmaceutica Verenigde Staten

Financials

Key metrics

Market capitalisation, EUR 6.736 m
EPS, EUR 1,36
P/B ratio 13,3
P/E ratio 35,8
Dividend yield 0,00%

Income statement (2025)

Revenue, EUR 752 m
Net income, EUR -1 m
Profit margin -0,20%

What ETF is Arrowhead Pharmaceuticals in?

There are 6 ETFs which contain Arrowhead Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Arrowhead Pharmaceuticals is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
Amundi MSCI Disruptive Technology UCITS ETF Acc 0,09%
Equity
World
Technology
Social/Environmental
Innovation
132
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0,71%
Equity
United States
Health Care
Biotech
47
iShares S&P SmallCap 600 UCITS ETF 0,61%
Equity
United States
Small Cap
2,254
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0,01%
Equity
World
Social/Environmental
480
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0,02%
Equity
North America
Social/Environmental
24
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0,13%
Equity
United States
Small Cap
187
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.